Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial Development

Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial Development

The global increase in the prevalence of drug-resistant bacteria has necessitated the development of alternative treatments that do not rely on conventional antimicrobial agents. Using bacteriophage-derived lytic enzymes in antibacterial therapy shows promise; however, a thorough comparison and eval...

Full description

Bibliographic Details
Main Authors: Wakana Yamashita, Shinjiro Ojima, Azumi Tamura, Aa Haeruman Azam, Kohei Kondo, Zhang Yuancheng, Longzhu Cui, Masaki Shintani, Masato Suzuki, Yoshimasa Takahashi, Koichi Watashi, Satoshi Tsuneda, Kotaro Kiga
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2024-01-01
Series:BioDesign Research
Online Access:https://spj.science.org/doi/10.34133/bdr.0028

Internet

https://spj.science.org/doi/10.34133/bdr.0028

Similar Items